2018 SPEAKERS CONFIRMED TO DATE

  1. Susan Welsh , Chief Safety Officer, CSL Behring

  2. Felix Arellano , Global Head of Pharmacovigilance and Drug Safety, Roche

  3. Lisa Benaise , Global Head, Device Safety, Galderma

  4. Keya Pitts , Global Head of PV Q/A, Astellas

  5. Mircea Ciuca , Global Head Medical & Clinical Drug Safety, Vifor Pharma

  6. Rudi Scheerlinck , Head Global Drug Safety, Basilea Pharmaceutica Ltd

  7. Lykke Bjerglund Graff , Head of Global Pharmacovigilance, LEO Pharma

  8. Marco Sardella , Chief Pharmacovigilance Officer & EU QPPV, Adienne

  9. Fabio De Gregorio , Vice President, Head of Drug Safety EU, QPPV, Shionogi Limited

  10. Howard Snow , Therapy Area Safety Lead Ophthalmology, Drug Safety and Epidemiology, Novartis 

  11. Salvatore Giorgio Cicirello , Senior Director Pharmacovigilance Innovation, Global Drug Safety & Risk Management, Celgene

  12. Diane Beck , Vice President, Head of Pharmacovigilance Services, Takeda 

  13. Maria Vazquez-Gragg , Vice President, Head of Global Patient Safety, Intarcia Therapeutics

  14. Mirza Rahman , Vice President, Clinical Safety & Pharmacovigilance & Global Head of Pharmacovigilance, Otsuka

  15. Peter De Veene , Senior VP & Head of Global Drug Safety and Qualified Person for Pharmacovigilance, Grünenthal

  16. Calvin Johnson , Director, Affiliate Vigilance Excellence, AbbVie

  17. David Chonzi , VP, Patient Safety and Risk Management, Gilead Sciences

  18. Jørgen Matz , Senior Director, Head of Medical Safety, Global Pharmacovigilance, Lundbeck

  19. Wally Landsberg , Director, Global Safety Lead Physician, Otsuka Europe Development and Commercialisation Ltd

  20. Tanja Peters , Head PV Intelligence & Deputy EU QPPV, Boehringer Ingelheim

  21. Anna Adams , GPvP Inspector, MHRA

  22. Jorge Gonzalez Borroto , Pharmacovigilance Officer/Nonclinical Toxicology Expert, Ferrer Internacional S.A.

  23. Matthias Boedding , Senior Director, Merck

  24. Vikesh Srivastava , Associate Director Business Informatics, Health Canada

  25. Bert van Leeuwen , Deputy QPPV, Astellas

  26. Francesco Tescione , Sr. Pharmacovigilance Manager & Eu-QPPV, Molteni Farmaceutici

  27. Pieter Stolk , Program Manager, Lygature

  28. Jackie Roberts , Executive Director – Regulatory, Pharmacovigilance and Medical, Actavis

  29. Thomas Häufel , Head Early Safety & Due Diligence Deputy QPPV, Grünenthal

  30. Celine Adessi , Group Head, Oncology, Clinical Safety Science Leader, Roche

  31. Jo Emmott , Deputy EU QPPV, MSD

  32. Jason Zielonka , Medical Fellow, Global Patient Safety (GPS), Eli Lilly and Company

  33. Romualdo Beningni , Independent, Alpha-Pretox

  34. Thomas Stuhr , Head of Corporate Pharmacovigilance, Meda

  35. Doris Stenver , Chief Medical Officer, Danish Medicines Agency and Member of Pharmacovigilance Risk Assessment Committee (PRAC), EMA

  36. Pedro Lima , LATAM Regional Safety Lead, Emerging Markets Safety | Global Pharmacovigilance & Epidemiology, Sanofi

  37. John Solomon , Head of Pharmacovigilance-UK & Ireland, Sanofi

  38. Barbara Morollo , Head, Pharmacovigilance Operations, Moderna Therapeutics

  39. Yusuf Tanrikulu , Global Process Owner Signal Management, Roche

  40. Stephen Heaton , Head of Center of Excellence Risk Management Sciences, Bayer

  41. Maddalena Lino , Therapeutic Area Safety Head, Seqirus

  42. Giovanni Furlan , EU QPPV, Sr Director, Seqirus

  43. Ricarda Tiemeyer , Head of Drug Safety & PoC Medical Information, Local Safety Responsible, Roche 

  44. Julia Appelskog , PV Strategy Director, Merck

  45. Jayne Lawrence , Head of Division of Pharmacy and Optometry, University of Manchester

  46. Sunayana Shah , Head of Regulatory and Safety Policy, The Association of the British Pharmaceutical Industry (ABPI)

  47. Rawya Al Kredly , Head of Medical Affairs Department, Julphar

  48. Yasmine Boulkroun , Head of Global Vigilances Department, Pierre Fabre

  49. Miroslava Nováková , Drug Safety & Medical Information Manager, GSK

  50. Rishi Chopra , Director, Head of Global PV Network Operations (Post Marketing) | SABR, Deputy EU QPPV, Biogen

  51. Thomas Gerloff , Risk Management Pharmacovigilance, Boehringer Ingelheim

  52. Greg Ball , Principal Statistician, Merck

  53. Uwe Gudat , Head of Safety, Biosimilars, Fresenius Kabi

  54. Dennis Vargo , Global Safety Leader, Takeda

  55. Ben Locwin , President, Healthcare Science Advisors

  56. Jan Cleerbout , Director, Medical Safety Officer, Johnson & Johnson

  57. Ashish Jain , Head of Pharmacovigilance, Curis

  58. Dimitar Tonev , Medical Director, Promethera Bioscience

  59. Fernando Solimado , Senior Risk Management Physician, Boehringer Ingelheim

  60. Mariska Kooijmans-Coutinho , Head of Drug Safety and Pharmacovigilance International and EU QPPV, Amicus Therapeutics

  61. Kevin Tynan , Contract Consultant, GCSP Regions and Pv Operations, Global Clinical Safety and Pharmacovigilance, CSL Behring

  62. Nadia Español , Senior Drug Safety Specialist, mAbxience

  63. Monika Manske , Associate Director of Global Pharmacovigilance Governance, Mylan Healthcare GmbH

 

 

DOWNLOAD PROSPECTUS

 

 

Get involved

If you’d like to become an exhibitor, sponsor or speaker at the event
contact Edmond Rama  at edmond.rama@terrapinn.com
or +44 (0)20 7092 1052